|
IGIV: Achieving Improved Patient Outcomes, Vol. 1, Issue 2
IGIV Use in Neurologic Diseases
IGIV Use in Neurologic Diseases
is the second issue in a 4-part newsletter series,
IGIV: Achieving Improved Patient Outcomes. Its goal is to familiarize
physicians, nurses, and pharmacists with the latest developments in the
field of immune globulin intravenous (IGIV) therapy, its relevance to
patient care, and the clinical implications of pharmacologic differences
among various treatment choices. This issue highlights the rationale for and
current approach to using IGIV to treat GBS, CIDP, MMN, and MG. A case
report illustrates clinical challenges in treating MG.
This activity is supported by an unrestricted educational
grant from Talecris Biotherapeutics, Center for Science and Education.
Please contact Continuing Education Alliance at
inquiries@cealliance.org for questions regarding this activity.
Release date:
February 15, 2008
Expiration: February 15, 2009
|
